Skip to main content
. 2014 May 14;2014:467465. doi: 10.1155/2014/467465

Table 6.

Effect of ellagic acid on the benzo[a]pyrene induced mutagenicity in Salmonella typhimurium.

Treatment Dose (μM) Number of His+ revertants colonies/plate (mean ± SE)
TA 97a TA 98 TA 100 TA 102
Spontaneous 144.0 ± 8.7 39.7 ± 3.8 140.3 ± 10.8 325.7 ± 16.6
Positive control (BP) 1.5 μg 736.7 ± 30.1 165.7 ± 10.2 704.3 ± 27.0 694.0 ± 20.8
aEllagic acid 50 142.3 ± 10.7 50.0 ± 5.1 136.3 ± 12.0 336.0 ± 23.0
100 159.7 ± 10.5 44.7 ± 3.8 162.7 ± 16.6 275.0 ± 16.8
250 175.0 ± 15.0 38.3 ± 2.3 178.0 ± 12.7 308.0 ± 17.2
500 184.0 ± 10.6 32.0 ± 3.6 188.7 ± 12.8 302.0 ± 17.1
bEllagic acid + BP 50 652.7 ± 35.3 (14.1) 140.0 ± 12.2 (22.2) 580.3 ± 25.6* (21.8) 653.0 ± 34.7 (11.5)
100 529.0 ± 28.6** (36.0) 107.3 ± 7.9* (48.2) 472.3 ± 19.4** (42.8) 595.0 ± 24.1* (23.6)
250 333.3 ± 22.2*** (71.8) 86.3 ± 5.8** (62.3) 336.0 ± 17.6*** (70.0) 514.0 ± 21.4** (46.6)
500 275.3 ± 17.5*** (83.5) 60.7 ± 10.5** (78.6) 245.7 ± 14.4*** (88.9) 366.0 ± 25.0*** (83.7)

R 2 098 0.97 0.99 0.93

aNegative control; bpreincubation test; values in parenthesis are % inhibition of mutagenicity.

*P < 0.05; **P < 0.005 and ***P < 0.001; B[a]P: benzo[a]pyrene; R 2: linear regression analysis.